Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 10, 2025
Reporting period
Not applicable
Filed with the SEC
Dec 12, 2025
CFOTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001104659-25-120668
Filed / recorded
Dec 12, 2025, 9:17 PM UTC
Added to OQRO
Oct 8, 2026, 12:54 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Orchestra BioMed Holdings, Inc.
Issuer CIK
1814114
Ticker
OBIO
Reporting person
Andrew Lawrence Taylor
Relationship
Officer
Officer title
Chief Financial Officer
Security
Common Stock, par value $0.0001 per share
Table
Non-derivative (Table I)
Transaction date
Dec 10, 2025
Transaction code
F
Shares / units
8,670
Price per share
$4.67
Acquired / disposed
Disposed (D)
Shares owned after
454,945
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.